| Selenium in Preventing Prostate Cancer (NCT00978718) | University of Arizona | 2001-08-01 |
| Proteases in Patients With Prostate Cancer That Has Spread to the Bone (NCT00899665) | Barbara Ann Karmanos Cancer Institute | 2001-07-01 |
| S0000 Selenium and Vitamin E in Preventing Prostate Cancer (NCT00006392) | SWOG Cancer Research Network | 2001-07-01 |
| Gene-Environment Interaction in Prostate Cancer (NCT00041847) | National Institute of Environmental Health Sciences (NIEHS) | 2001-07-01 |
| A Long Term Safety Study With Atrasentan (NCT00127478) | Abbott | 2001-07-01 |
| MRI-guided Bone Marrow Biopsies of Prostate Cancer Patients (NCT00165386) | Dana-Farber Cancer Institute | 2001-07-01 |
| Ixabepilone With or Without Estramustine in Treating Patients With Progressive Prostate Cancer (NCT00025194) | Memorial Sloan Kettering Cancer Center | 2001-07-01 |
| Prostate Testing for Cancer and Treatment (NCT02044172) | University of Oxford | 2001-06-01 |
| S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer (NCT00023634) | SWOG Cancer Research Network | 2001-06-01 |
| Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer (NCT00024232) | Memorial Sloan Kettering Cancer Center | 2001-06-01 |
| BMS-247550 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00016393) | SWOG Cancer Research Network | 2001-06-01 |
| Chemotherapy, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer (NCT00016913) | Alliance for Clinical Trials in Oncology | 2001-05-01 |
| Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia (NCT00127387) | The University of Texas Health Science Center at San Antonio | 2001-05-01 |
| Pre-Prostatectomy Celecoxib or Placebo (NCT02840162) | OHSU Knight Cancer Institute | 2001-05-01 |
| A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer (NCT00036543) | Abbott | 2001-05-01 |
| Open Label Trial to Assess Iressa in Prostate Cancer Patients (NCT00635856) | AstraZeneca | 2001-05-01 |
| Tetrathiomolybdate in Hormone Refractory Prostate Cancer (NCT00150995) | University of Michigan Rogel Cancer Center | 2001-05-01 |
| ZD 1839 in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00025116) | NCIC Clinical Trials Group | 2001-04-24 |
| Chemotherapy With or Without Biological Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005847) | Eastern Cooperative Oncology Group | 2001-04-05 |
| Toremifene Followed by Radical Prostatectomy in Treating Patients With Stage I or Stage II Prostate Cancer (NCT00020735) | Joel Nelson, MD | 2001-04-01 |
| Prostate Immobilization Device Used During Radiation Treatments to Decrease Rectal Bleeding (NCT00114985) | Dana-Farber Cancer Institute | 2001-04-01 |
| Radiation Therapy With or Without Bicalutamide and Goserelin in Treating Patients With Prostate Cancer (NCT00021450) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-04-01 |
| DHA-Paclitaxel in Treating Patients With Metastatic Prostate Cancer (NCT00024414) | Theradex | 2001-04-01 |
| Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00009750) | University of California, Davis | 2001-03-01 |
| CT Scans in Guiding the Treatment of Patients With Prostate Cancer Who Are Undergoing Radiation Therapy (NCT00020891) | Memorial Sloan Kettering Cancer Center | 2001-03-01 |
| The Efficacy and Safety of FE 200486 in Treatment of Patients Suffering From Prostate Cancer (NCT00819247) | Ferring Pharmaceuticals | 2001-03-01 |
| A Phase III Intensity Radiotherapy Dose Escalation for Prostate Cancer Using Hypofractionation (NCT00667888) | M.D. Anderson Cancer Center | 2001-01-03 |
| Docetaxel Followed by Radical Prostatectomy in Patients With High Risk Localized Prostate Cancer (NCT01250717) | Beth Israel Deaconess Medical Center | 2001-01-01 |
| Effects of Alpha Blockers on Prostate-specific Antigen (PSA) Change in Men With Lower Urinary Tract Symptoms (LUTS) (NCT01250483) | Seoul National University Hospital | 2001-01-01 |
| Early Stage Prostate Cancer Cohort (NCT00011349) | US Department of Veterans Affairs | 2001-01-01 |
| Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer (NCT00014586) | European Organisation for Research and Treatment of Cancer - EORTC | 2001-01-01 |
| Green Tea Extract in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005828) | Alliance for Clinical Trials in Oncology | 2000-12-01 |
| Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00017576) | OHSU Knight Cancer Institute | 2000-12-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005992) | Jonsson Comprehensive Cancer Center | 2000-12-01 |
| Study on the Role of Hormonal Treatment for Two Dosage Levels of Prostate Radiation Therapy Versus Prostate Radiation Therapy Alone (NCT00223145) | Abdenour Nabid | 2000-12-01 |
| Magnetic Resonance Imaging and Spectroscopy of the Prostate (NCT00590993) | Memorial Sloan Kettering Cancer Center | 2000-12-01 |
| Leuvectin in Treating Patients With Locally Recurrent Prostate Cancer (NCT00005072) | Vical | 2000-11-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer (NCT00010127) | Duke University | 2000-11-01 |
| External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer (NCT00006365) | Radiation Therapy Oncology Group | 2000-11-01 |
| Preoperative Thalidomide Followed By Radical Retropubic Prostatectomy In Select Patients With Locally Advanced Prostate Cancer (NCT00038181) | M.D. Anderson Cancer Center | 2000-10-05 |
| Duration of Androgen Blockade Combined With Pelvic Irradiation in Prostate Cancers (NCT00223171) | Université de Sherbrooke | 2000-10-01 |
| Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma (NCT00038246) | M.D. Anderson Cancer Center | 2000-10-01 |
| CCI-779 in Treating Patients With Prostate Cancer (NCT00012142) | Jonsson Comprehensive Cancer Center | 2000-09-01 |
| Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer (NCT00014352) | Memorial Sloan Kettering Cancer Center | 2000-09-01 |
| Rosiglitazone (Avandia) vs. Placebo for Androgen Dependent Prostate Cancer (NCT00182052) | Massachusetts General Hospital | 2000-09-01 |
| Combination Chemotherapy Followed by Surgery in Treating Patients With Localized Prostate Cancer (NCT00017563) | OHSU Knight Cancer Institute | 2000-09-01 |
| Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer (NCT00006359) | Alliance for Clinical Trials in Oncology | 2000-09-01 |
| Monoclonal Antibody Therapy in Treating Patients With Prostate Cancer (NCT00006380) | Memorial Sloan Kettering Cancer Center | 2000-09-01 |
| Trastuzumab and Docetaxel in Treating Patients Who Have Metastatic Prostate Cancer That Is Refractory to Hormone Therapy (NCT00005857) | City of Hope Medical Center | 2000-08-01 |
| Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate (NCT00006214) | Alliance for Clinical Trials in Oncology | 2000-08-01 |
| Weekly Paclitaxel, Low-Dose Estramustine, and Carboplatin in the Treatment of Hormone Refractory Prostate Carcinoma (NCT00193193) | SCRI Development Innovations, LLC | 2000-08-01 |
| Behavior-Based Dietary Intervention in Treating Patients With Hormone-Refractory Prostate Cancer (NCT00082732) | M.D. Anderson Cancer Center | 2000-07-28 |
| Vaccine Therapy Plus Biological Therapy in Treating Patients With Prostate Cancer (NCT00016146) | Memorial Sloan Kettering Cancer Center | 2000-07-01 |
| PSA-Based Vaccine and Radiotherapy to Treat Localized Prostate Cancer (NCT00005916) | National Cancer Institute (NCI) | 2000-06-13 |
| SU5416 Compared to Dexamethasone in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00006002) | University of Chicago | 2000-06-01 |
| Lycopene In Preventing of Prostate Cancer (NCT00006078) | University of Illinois at Chicago | 2000-06-01 |
| Vaccine Therapy Plus Sargramostim and Interleukin-2 Compared With Nilutamide Alone in Treating Patients With Prostate Cancer (NCT00020254) | National Cancer Institute (NCI) | 2000-06-01 |
| Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma (NCT00038168) | M.D. Anderson Cancer Center | 2000-06-01 |
| Prostate Cancer Prospective Cohort (NCT00937586) | Washington University School of Medicine | 2000-05-01 |
| Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer (NCT00005028) | University of Maryland, Baltimore | 2000-05-01 |
| Phenylbutyrate Plus Azacitidine in Treating Patients With Acute Myeloid Leukemia, Myelodysplasia, Non-Hodgkin's Lymphoma, Multiple Myeloma, Non-small Cell Lung Cancer, or Prostate Cancer (NCT00006019) | Memorial Sloan Kettering Cancer Center | 2000-05-01 |
| Nitrocamptothecin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005820) | Alliance for Clinical Trials in Oncology | 2000-05-01 |
| A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer (NCT00006371) | H. Lee Moffitt Cancer Center and Research Institute | 2000-05-01 |
| Effects of Soy Compounds on Breast Cancer, Prostate Cancer, and Bone Health (NCT00200824) | National Center for Complementary and Integrative Health (NCCIH) | 2000-05-01 |
| Safety Study of Combination of Hormone Therapy, Paclitaxel and Radiation Therapy to Treat Prostate Cancer (NCT02911350) | NYU Langone Health | 2000-05-01 |
| Study of Histrelin Subdermal Implant in Patients With Prostate Cancer (NCT01394263) | Endo USA Inc., a Keenova Therapeutics Company | 2000-05-01 |
| Study to Evaluate Efficacy and Safety of Histrelin Subdermal Implant in Men With Advanced Prostate Cancer (NCT01697384) | Endo USA Inc., a Keenova Therapeutics Company | 2000-04-01 |
| R115777 in Treating Patients With Progressive, Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005848) | Fox Chase Cancer Center | 2000-04-01 |
| Leuprolide, Bicalutamide, and Implant Radiation Therapy in Treating Patients With Locally Recurrent Prostate Cancer After External-Beam Radiation Therapy (NCT00684905) | Mayo Clinic | 2000-04-01 |
| Monoclonal Antibody ABX-EGF in Treating Patients With Renal (Kidney), Prostate, Pancreatic, Non-Small Cell Lung, Colon or Rectal, Esophageal, or Gastroesophageal Junction Cancer (NCT00004879) | Jonsson Comprehensive Cancer Center | 2000-04-01 |
| Intensity-Modulated Radiation Therapy in Treating Patients With Prostate Cancer (NCT00946543) | Royal Marsden NHS Foundation Trust | 2000-03-01 |
| Germline Alterations of Tumor Susceptibility Genes in New York Cancer Patients (NCT00579514) | Memorial Sloan Kettering Cancer Center | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005810) | Alliance for Clinical Trials in Oncology | 2000-03-01 |
| Capecitabine in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00006023) | Swiss Cancer Institute | 2000-03-01 |
| Combination Chemotherapy Plus Filgrastim in Treating Patients With Advanced Solid Tumors (NCT00014456) | Dartmouth-Hitchcock Medical Center | 2000-03-01 |
| Thalidomide for the Treatment of Hormone-Dependent Prostate Cancer (NCT00004635) | National Cancer Institute (NCI) | 2000-03-01 |
| Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer (NCT00005044) | Radiation Therapy Oncology Group | 2000-02-01 |
| S9917, Selenium in Preventing Cancer in Patients With Neoplasia of the Prostate (NCT00030901) | SWOG Cancer Research Network | 2000-02-01 |
| Soy Protein Supplement in Preventing Prostate Cancer in Patients With Elevated Prostate-Specific Antigen Levels (NCT00031746) | Alliance for Clinical Trials in Oncology | 2000-02-01 |
| Testosterone in Treating Patients With Progressive Prostate Cancer That No Longer Responds to Hormone Therapy (NCT00006044) | Memorial Sloan Kettering Cancer Center | 2000-02-01 |
| Vaccine Therapy in Treating Patients With Recurrent Prostate Cancer (NCT00030602) | University of Maryland, Baltimore | 2000-01-01 |
| Suberoylanilide Hydroxamic Acid in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Therapy (NCT00005634) | Memorial Sloan Kettering Cancer Center | 2000-01-01 |
| Study to Determine the Prevalence of Osteoporosis in Patients With Advanced Prostate Cancer Treated With Hormonal Manipulation (NCT00124410) | AHS Cancer Control Alberta | 2000-01-01 |
| Hormone Therapy Plus Radiation Therapy With or Without Combination Chemotherapy in Treating Patients With Prostate Cancer (NCT00004054) | Radiation Therapy Oncology Group | 2000-01-01 |
| Cyproterone Acetate in Treating Hot Flashes Following Surgical or Chemical Castration for Prostate Cancer (NCT00005623) | Barr Laboratories | 1999-12-01 |
| Docetaxel in Treating Patients With Stage II or Stage III Prostate Cancer (NCT00005096) | Dana-Farber Cancer Institute | 1999-12-01 |
| EF5 Prior to Surgery or Biopsy in Patients With Breast, Prostate, or Cervical Cancer or High Grade Soft Tissue Sarcoma (NCT00004261) | University Health Network, Toronto | 1999-12-01 |
| Genistein in Treating Patients With Stage II, Stage III, or Stage IV Prostate Cancer (NCT00005827) | UNC Lineberger Comprehensive Cancer Center | 1999-12-01 |
| Vaccine Therapy in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005947) | Dendreon | 1999-11-01 |
| Brachytherapy in Treating Patients With Recurrent Prostate Cancer (NCT00005939) | Center for Molecular Medicine | 1999-11-01 |
| S9921, Hormone Therapy With or Without Mitoxantrone and Prednisone in Patients Who Have Undergone Radical Prostatectomy for Prostate Cancer (NCT00004124) | SWOG Cancer Research Network | 1999-10-15 |
| Prognostic Factors in Prostate Cancer for Patients Treated by Watchful Waiting (NCT03912883) | Queen Mary University of London | 1999-10-12 |
| Combination Chemotherapy in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00005960) | Amgen | 1999-10-01 |
| S9916, Combination Therapy in Treating Patients With Advanced Prostate Cancer That Has Not Responded to Hormone Therapy (NCT00004001) | SWOG Cancer Research Network | 1999-10-01 |
| Calcifidol Therapy in Men With Cancer (NCT00018538) | US Department of Veterans Affairs | 1999-10-01 |
| Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer (NCT00004928) | Memorial Sloan Kettering Cancer Center | 1999-10-01 |
| PSA Vaccine Therapy in Treating Patients With Advanced Prostate Cancer (NCT00003871) | Eastern Cooperative Oncology Group | 1999-09-24 |
| Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate Cancer (NCT00004929) | Memorial Sloan Kettering Cancer Center | 1999-09-01 |
| Arsenic Trioxide in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Previous Hormone Therapy (NCT00004149) | Albert Einstein College of Medicine | 1999-09-01 |
| Zoledronate Plus Standard Therapy Compared With Placebo Plus Standard Therapy to Prevent Bone Metastases in Patients With Recurrent Prostate Cancer That Has No Symptoms (NCT00005073) | Novartis Pharmaceuticals | 1999-09-01 |